REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

E.S.E. Hospital Universitario de Santander (Colombia)

Main Activities: Hospitals
Full name: E.S.E. Hospital Universitario de Santander Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

E.S.E. Hospital Universitario de Santander is based in Colombia, with the head office in Bucaramanga. The company operates in the Hospitals industry. It was established on December 23, 2014. In Q3C2024, the company reported a net sales revenue increase of 15.8%. Its total assets decreased by 4.81% over the same period. The net profit margin of E.S.E. Hospital Universitario de Santander increased by 4.14% in 2024.

Headquarters
Cra 33 28 126
Bucaramanga; Santander; Postal Code: 680002

Contact Details: Purchase the E.S.E. Hospital Universitario de Santander report to view the information.

Website: http://www.hus.gov.co

Basic Information
Outstanding Shares:
Purchase the E.S.E. Hospital Universitario de Santander report to view the information.
Incorporation Date:
December 23, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Treasurer
Purchase this report to view the information.
Head of Internal Control
Company Performance
Financial values in the chart are available after E.S.E. Hospital Universitario de Santander report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
15.8%▲
Total operating revenue
13.22%▲
Operating profit (EBIT)
56.43%▲
EBITDA
6.14%▲
Net Profit (Loss) for the Period
51.01%▲
Total assets
-4.81%▼
Total equity
-4.75%▼
Operating Profit Margin (ROS)
3.18%▲
Net Profit Margin
4.14%▲
Return on Equity (ROE)
3.39%▲
Quick Ratio
-0.77%▼
Cash Ratio
-0.27%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo